Table 1 Demographical and clinical features of the study cohort.
Total | No Infection | Infection | p | No Pneumonia | Pneumonia | p | |
|---|---|---|---|---|---|---|---|
n = 1,543 | n = 1,263 | n = 280 | n = 1,384 | n = 159 | |||
Sex M, n(%) | 639(41.4%) | 523(41.4%) | 116(41.4%) | 0.995 | 556(40.2%) | 83(52.2%) | 0.004 |
Age, median(IQR) | 85(80–89) | 84(80–89) | 87(83–91) | < 0.001 | 85(80–89) | 87(83–90) | < 0.001 |
Dementia, n(%) | 598(38.8%) | 474(37.5%) | 124(44.3%) | 0.036 | 522(37.7%) | 76(47.8%) | 0.013 |
Stroke, n(%) | 313(20.3%) | 228(18.1%) | 85(30.4%) | < 0.001 | 263(19%) | 50(31.4%) | < 0.001 |
Diabetes, n(%) | 350(22.7%) | 294(23.3%) | 56(20.0%) | 0.236 | 324(23.4%) | 26(16.4%) | 0.044 |
Antipsychotic drugs, n(%) | 228(14.8%) | 176(13.9%) | 52(18.6%) | 0.048 | 200(14.5%) | 28(17.6%) | 0.288 |
Days of hospitalization, median(IQR) | 11(7–17) | 10(6–15) | 19(11–27) | < 0.001 | 10(7–16) | 21(12–32) | < 0.001 |
Devices | |||||||
CVC, n(%) | 22(1.4%) | 12(1.0%) | 10(3.6%) | 0.001 | 14(1%) | 8(5%) | < 0.001 |
Days CVC, median(IQR) | 3.5(2–9) | 3.5(2–9) | 4(3–7) | 0.484 | 3(2–9) | 6(3–14) | 0.285 |
Power Glide, n(%) | 6(0.4%) | 5(0.4%) | 1(0.4%) | 0.925 | 5(0.4%) | 1(0.6%) | 0.608 |
Days Power Glide, median(IQR) | 1(1–7) | 1(1–7) | 1(1–1) | 0.480 | 1(1–7) | 1(1–1) | 0.480 |
PVC, n(%) | 864(56%) | 659(52.2%) | 205(73.2%) | < 0.001 | 749(54.1%) | 115(72.3%) | < 0.001 |
Days PVC, median(IQR) | 5(3–9) | 4(3–8) | 6(3–13) | < 0.001 | 4(3–8) | 6(3–15) | < 0.001 |
PICC, n(%) | 33(2.1%) | 22(1.7%) | 11(3.9%) | 0.022 | 22(1.6%) | 11(6.9%) | < 0.001 |
Days PICC, median(IQR) | 1(1–4) | 1(1–10) | 1(1–1) | 0.343 | 1(1–10) | 1(1–1) | 0.343 |
Nasogastric tube, n(%) | 57(3.7%) | 26(2.1%) | 31(11.1%) | < 0.001 | 34(2.5%) | 23(14.5%) | < 0.001 |
Days nasogastric tube, median(IQR) | 3(1–27) | 2.5(1–13) | 6(1–29) | 0.771 | 1.5(1–10) | 10(1–31) | 0.144 |
Midline, n(%) | 44(2.9%) | 21(1.7%) | 23(8.2%) | < 0.001 | 24(1.7%) | 20(12.6%) | < 0.001 |
Days Midline, median(IQR) | 2.5(1–7.5) | 2(1–7) | 4(1–11) | 0.363 | 2.5(1–7) | 3(1–8) | 0.810 |
Urinary catheter, n(%) | 164(10.6%) | 77(6.1%) | 87(31.1%) | < 0.001 | 109(7.9%) | 55(34.6%) | < 0.001 |
Days Urinary catheter, median(IQR) | 22.5(7–30) | 14(4–29) | 29(13–31) | 0.010 | 15(7–29) | 29(16–31) | 0.004 |
Total | No Urinary Infection | Urinary Infection | p | No Blood Infection | Blood Infection | p | |
|---|---|---|---|---|---|---|---|
n = 1,543 | n = 1,388 | n = 155 | n = 1,526 | n = 17 | |||
Sex M, n(%) | 639(41.4%) | 593(42.7%) | 46(29.7%) | 0.002 | 634(41.5%) | 5(29.4%) | 0.312 |
Age, median(IQR) | 85(80–89) | 84(80–89) | 87(83–91) | < 0.001 | 85(80–89) | 88(85–91) | 0.075 |
Dementia, n(%) | 598(38.8%) | 538(38.8%) | 60(38.7%) | 0.990 | 592(38.8%) | 6(35.3%) | 0.768 |
Stroke, n(%) | 313(20.3%) | 267(19.2%) | 46(29.7%) | 0.002 | 307(20.1%) | 6(35.3%) | 0.122 |
Diabetes, n(%) | 350(22.7%) | 319(23.0%) | 31(20.0%) | 0.400 | 348(22.8%) | 2(11.8%) | 0.280 |
Antipsychotic drugs, n(%) | 228(14.8%) | 198(14.3%) | 30(19.4%) | 0.090 | 222(14.5%) | 6(35.3%) | 0.017 |
Days of hospitalization, median(IQR) | 11(7–17) | 10(7–16) | 20(11–26) | < 0.001 | 11(7–17) | 43(25–54) | < 0.001 |
Devices | |||||||
CVC, n(%) | 22(1.4%) | 18(1.3%) | 4(2.6%) | 0.201 | 20(1.3%) | 2(11.8%) | < 0.001 |
Days CVC, median(IQR) | 3.5(2–9) | 3.5(2–9) | 5(3–19) | 0.465 | 3.5(2–8) | 17(3–31) | 0.419 |
Power Glide, n(%) | 6(0.4%) | 6(0.4%) | 0(0%) | 0.412 | 6(0.4%) | 0(0%) | 0.796 |
Days Power Glide, median(IQR) | 1(1–7) | 1(1–7) | – | – | 1(1–7) | – | – |
PVC, n(%) | 864(56%) | 747(53.8%) | 117(75.5%) | < 0.001 | 852(55.8%) | 12(70.6%) | 0.223 |
Days PVC, median(IQR) | 5(3–9) | 4(3–9) | 6(3–12) | 0.010 | 4.5(3–9) | 11(4–28.5) | 0.015 |
PICC, n(%) | 33(2.1%) | 31(2.2%) | 2(1.3%) | 0.441 | 33(2.2%) | 0(0%) | 0.540 |
Days PICC, median(IQR) | 1(1–4) | 1(1–4) | 7.5(1–14) | 0.532 | 1(1–4) | – | – |
Nasogastric tube, n(%) | 57(3.7%) | 40(2.9%) | 17(11%) | < 0.001 | 50(3.3%) | 7(41.2%) | < 0.001 |
Days SNG, median(IQR) | 3(1–27) | 2(1–14.5) | 10(1–34) | 0.157 | 2.5(1–16) | 29(1–35) | 0.015 |
Midline, n(%) | 44(2.9%) | 33(2.4%) | 11(7.1%) | 0.001 | 41(2.7%) | 3(17.6%) | < 0.001 |
Days Midline, median(IQR) | 2.5(1–7.5) | 2(1–6) | 8(2–17) | 0.021 | 2(1–7) | 20(2–29) | 0.138 |
Urinary catheter, n(%) | 164(10.6%) | 110(7.9%) | 54(34.8%) | < 0.001 | 153(10.0%) | 11(64.7%) | < 0.001 |
Days Urinary catheter, median(IQR) | 22.5(7–30) | 21.5(7–30) | 23(9–31) | 0.498 | 21(7–30) | 29(29–50) | 0.064 |
